david gandara, md,, discusses pd-l1 expression and selecting the appropriate agent in nsclc patients
Published 8 years ago • 46 plays • Length 0:58
Download video MP4
Download video MP3
Similar videos
-
0:47
david ettinger, md, talks about levels of pd-l1 expression and agent selection
-
1:50
pd-l1 agents in the treatment of nsclc
-
1:02
david gandara, md, current thinking regarding testing for pd-l1 biomarker in nsclc patients
-
1:21
poet: the predictive and prognostic value of pd-l1 expression in nsclc
-
0:46
david gandara, md, discusses considerations when choosing between immunotherapy and chemotherapy
-
8:05
how does pd-l1 score affect treatment options? - lung cancer onctalk 2022
-
6:56
all you need to know about pd-l1 by immunohistochemistry
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
1:32
david gandara, md, talks about the potential impact of immunotherapy in 1st line nsclc
-
1:42
dr. gandara discusses pd-l1 as a biomarker in lung cancer
-
2:19
combining ctla-4 agents with pd-1/pd-l1 agents in lung cancer
-
0:48
julie brahmer, md, on the level of pd-l1 expression in selecting the appropriate agent in nsclc
-
1:30
david r. gandara, md, on whether keynote 189 impacted view of pdl-1 expression and patient selection
-
8:22
pd-l1 expression predicts which solid tumor patients will respond to pd-1/pd-l1 treatment
-
2:03
dr. david gandara discusses multiplexing molecular tests for nsclc
-
0:59
david gandara, md, discusses the positioning of cyramza post platinum therapy in nsclc patients
-
1:41
david r. gandara, md, discusses drug sequencing as a result of keynote 189 and 42 results
-
1:34
dr. david gandara on patient selection for molecular testing in lung cancer
-
1:02
dr. gubens discusses the role of pd-l1 in patients with nsclc
-
1:20
dr. david gandara describes exciting new lung cancer research
-
0:31
david gandara, md, discusses pembrolizumab vs docetaxel for previously treated nsclc patients
-
0:44
david r. gandara, md, discusses exciting new developments in lung cancer here at asco 2018
Clip.africa.com - Privacy-policy